Lilly-Lupin link revs up Indian diabetes

A string of new marketing deals is set to redefine competition in the growing Indian diabetes market. The latest alliance involves Lilly and Lupin, where the Indian firm will promote and distribute Lilly's Huminsulin range in India and Nepal, doubling doctor reach for the insulin products to about 45,000 almost overnight.